Insider · CIK 0001715152
John Richard Martin
Files at DCPH (Deciphera Pharmaceuticals, Inc.). First filing -, latest -.
In brief
John Richard Martin files SEC Form 4 as director at DCPH (Deciphera Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; John Richard Martin has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 11, 2024 | DCPH Deciphera Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -52,000 | - | - | 0 | Jun 11, 2024 |
| Jun 11, 2024 | DCPH Deciphera Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,000 | - | - | 0 | Jun 11, 2024 |
| Jun 11, 2024 | DCPH Deciphera Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -18,500 | - | - | 0 | Jun 11, 2024 |
| Jun 11, 2024 | DCPH Deciphera Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -30,000 | - | - | 0 | Jun 11, 2024 |
| Jun 21, 2023 | DCPH Deciphera Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 23, 2023 |
Questions about John Richard Martin
Answered from the filings on this page, as of the latest one.
Is John Richard Martin buying or selling?
John Richard Martin has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did John Richard Martin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John Richard Martin has 0.
Where does John Richard Martin file Form 4?
John Richard Martin has filed Form 4 at DCPH (Deciphera Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.